Sun Pharma Recall

Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.

The recall is being initiated by Sun Pharmaceutical Industries Inc for 2,71,212 bottles of bupropion hydrochloride extended-release tablets, USP (SR) in the strengths of 150 mg and 200 mg, the FDA said.

The recall has been initiated by Sun Pharmaceutical Industries Inc for 31,762 bottles of bupropion hydrochloride extended-release tablets, USP (SR) in the strength of 150 mg, the US drug regulator said.

Drug major Sun Pharmaceutical Industries is recalling over 16,000 bottles of anti-depressant tablets from the US market due to failed dissolution specifications.

Around 3.8 lakh cartons of an osteoporosis drug manufactured by domestic drug major Sun Pharmaceutical Industries are being recalled in the US and Puerto Rico due to presence of "unknown impurity".

Drug major Sun Pharma is recalling over 10 lakh boxes of its anti-allergic Loratadine drug from the US market as the lot was found to be 'super potent' and 'out of specification'.

According to a notification issued by the US Food and Drug Administration, Sun Pharma's recall was initiated last month under Class-III classification which was as 'a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences'.

As per the information available on the USFDA website, Sun Pharma Global Fze, a US-based unit of the company, is recalling the eye drops for "presence of particulate matter" in the 5,322 batch of bottles.

The 750 mg tablets in 60-count bottles, were manufactured by Sun Pharmaceutical Industries at Halol.

As per the information available on the USFDA website, Sun Pharma Global Inc, a unit of the company, is recalling the drug for failing "dissolution specification".

According to reports, the drugmaker's US subsidiary Taro has recalled a blood clot drug because it reportedly did not meet US Food and Drug Administration standards.

The move was likely triggered by increased drug recalls from the Halol plant, analysts say. Other analysts said an inspection was due because the US regulator had last visited the Halol plant in September 2012.

According to a notification by the USFDA, the recall of the 3,40,553 units of 500 mg and 1,13,677 units of 250 mg bottles is voluntarily initiated by the company through a letter to the regulator in June under Class-II classification.

Sun Pharmaceutical Industries Ltd is recalling 41,127 bottles of antidepressant venlafaxine hydrochloride in the United States after the drug failed to dissolve properly, the US Food and Drug Administration (FDA) said.

The drug being recalled was manufactured by Sun Pharma's unit Caraco Pharmaceutical Laboratories Ltd at its plant in Gujarat, the FDA said in a post on its website.

Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.

The recall is being initiated by Sun Pharmaceutical Industries Inc for 2,71,212 bottles of bupropion hydrochloride extended-release tablets, USP (SR) in the strengths of 150 mg and 200 mg, the FDA said.

The recall has been initiated by Sun Pharmaceutical Industries Inc for 31,762 bottles of bupropion hydrochloride extended-release tablets, USP (SR) in the strength of 150 mg, the US drug regulator said.

Drug major Sun Pharmaceutical Industries is recalling over 16,000 bottles of anti-depressant tablets from the US market due to failed dissolution specifications.

Around 3.8 lakh cartons of an osteoporosis drug manufactured by domestic drug major Sun Pharmaceutical Industries are being recalled in the US and Puerto Rico due to presence of "unknown impurity".

Drug major Sun Pharma is recalling over 10 lakh boxes of its anti-allergic Loratadine drug from the US market as the lot was found to be 'super potent' and 'out of specification'.

According to a notification issued by the US Food and Drug Administration, Sun Pharma's recall was initiated last month under Class-III classification which was as 'a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences'.

As per the information available on the USFDA website, Sun Pharma Global Fze, a US-based unit of the company, is recalling the eye drops for "presence of particulate matter" in the 5,322 batch of bottles.

The 750 mg tablets in 60-count bottles, were manufactured by Sun Pharmaceutical Industries at Halol.

As per the information available on the USFDA website, Sun Pharma Global Inc, a unit of the company, is recalling the drug for failing "dissolution specification".

According to reports, the drugmaker's US subsidiary Taro has recalled a blood clot drug because it reportedly did not meet US Food and Drug Administration standards.

The move was likely triggered by increased drug recalls from the Halol plant, analysts say. Other analysts said an inspection was due because the US regulator had last visited the Halol plant in September 2012.

According to a notification by the USFDA, the recall of the 3,40,553 units of 500 mg and 1,13,677 units of 250 mg bottles is voluntarily initiated by the company through a letter to the regulator in June under Class-II classification.

Sun Pharmaceutical Industries Ltd is recalling 41,127 bottles of antidepressant venlafaxine hydrochloride in the United States after the drug failed to dissolve properly, the US Food and Drug Administration (FDA) said.

The drug being recalled was manufactured by Sun Pharma's unit Caraco Pharmaceutical Laboratories Ltd at its plant in Gujarat, the FDA said in a post on its website.